Tekla Capital Management’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | $10.6M | Hold |
|
|||||
|
2023
Q1 | $11.4M | Hold |
|
|||||
|
2022
Q4 | $13.5M | Sell |
|
|||||
|
2022
Q3 | $17.9M | Hold |
|
|||||
|
2022
Q2 | $16.4M | Buy |
|
|||||
|
2022
Q1 | $11.7M | Hold |
|
|||||
|
2021
Q4 | $10.6M | Hold |
|
|||||
|
2021
Q3 | $12M | Sell |
|
|||||
|
2021
Q2 | $20.7M | Hold |
|
|||||
|
2021
Q1 | $20.7M | Sell |
|
|||||
|
2020
Q4 | $28.2M | Buy |
|
|||||
|
2020
Q3 | $6.08M | Sell |
|
|||||
|
2020
Q2 | $25.1M | Hold |
|
|||||
|
2020
Q1 | $17.8M | Buy |
|
|||||
|
2019
Q4 | $20.8M | Sell |
|
|||||
|
2019
Q3 | $18.6M | Sell |
|
|||||
|
2019
Q2 | $17.5M | Sell |
|
|||||
|
2019
Q1 | $19.5M | Buy |
|
|||||
|
2018
Q4 | $15.4M | Buy |
|
|||||
|
2018
Q3 | $26.1M | Sell |
|
|||||
|
2018
Q2 | $26.5M | Sell |
|
|||||
|
2018
Q1 | $23.2M | Sell |
|
|||||
|
2017
Q4 | $25.2M | Sell |
|
|||||
|
2017
Q3 | $34.5M | Hold |
|
|||||
|
2017
Q2 | $25.9M | Buy |
|
|||||
|
2017
Q1 | $19.3M | Buy |
|
|||||
|
2016
Q4 | $15.2M | Sell |
|
|||||
|
2016
Q3 | $33.3M | Sell |
|
|||||
|
2016
Q2 | $34.9M | Buy |
|
|||||
|
2016
Q1 | $12.3M | Hold |
|
|||||
|
2015
Q4 | $17.6M | Sell |
|
|||||
|
2015
Q3 | $15M | Hold |
|
|||||
|
2015
Q2 | $18M | Sell |
|
|||||
|
2015
Q1 | $19.9M | Sell |
|
|||||
|
2014
Q4 | $22.3M | Sell |
|
|||||
|
2014
Q3 | $20.1M | Buy |
|
|||||
|
2014
Q2 | $11.7M | Buy |
|
|||||
|
2014
Q1 | $6.89M | Hold |
|
|||||
|
2013
Q4 | $4M | Sell |
|
|||||
|
2013
Q3 | $6.46M | Sell |
|
|||||
|
2013
Q2 | $9.47M | Buy |
|